News | October 11, 2021
Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
Subscribe To Our Newsletter & Stay Updated
